Effectiveness, safety, and patient-reported outcomes of treatment with bictegravir/emtricitabine/tenofovir alafenamide fixed dose combination in people living with HIV in Argentina: the BICTARG cohort.

Autor: Cecchini D; Diego Cecchini, Helios Salud SA, Perú 1511/15, Buenos Aires, C1141ACG, Argentina. dcecchini@heliossalud.com.ar., Brizuela M, Seleme MS, Mingrone MV, Copertari G, Bacelar B, Mauas R, Bottaro E, Cassetti I

Publikováno v: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia [Rev Esp Quimioter] 2024 Nov 20. Date of Electronic Publication: 2024 Nov 20.